WADDELL & REED FINANCIAL INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 88 filers reported holding REVANCE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
WADDELL & REED FINANCIAL INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,588,000
-9.5%
63,9000.0%0.00%0.0%
Q2 2018$1,754,000
-10.9%
63,9000.0%0.00%0.0%
Q1 2018$1,968,000
-13.8%
63,9000.0%0.00%
-20.0%
Q4 2017$2,284,000
-59.5%
63,900
-68.8%
0.01%
-61.5%
Q3 2017$5,638,000
-4.6%
204,650
-8.6%
0.01%0.0%
Q2 2017$5,911,000
+20.9%
223,900
-4.7%
0.01%
+30.0%
Q1 2017$4,888,000
-5.5%
235,000
-6.0%
0.01%
-9.1%
Q4 2016$5,175,000
+6.4%
250,000
-16.7%
0.01%
+10.0%
Q3 2016$4,863,000
+19.2%
300,0000.0%0.01%
+11.1%
Q2 2016$4,080,000
-34.0%
300,000
-15.2%
0.01%
-25.0%
Q1 2016$6,178,000
-68.3%
353,850
-38.0%
0.01%
-62.5%
Q4 2015$19,501,000
+74.2%
570,850
+51.8%
0.03%
+77.8%
Q3 2015$11,194,000
+12.8%
376,150
+21.2%
0.02%
+28.6%
Q2 2015$9,925,000
+42.8%
310,350
-7.5%
0.01%
+40.0%
Q1 2015$6,952,000
+17.6%
335,350
-3.9%
0.01%
+25.0%
Q4 2014$5,913,000
-18.7%
349,050
-7.2%
0.01%
-20.0%
Q3 2014$7,271,000
-43.8%
376,150
-1.2%
0.01%
-47.4%
Q2 2014$12,943,000
-22.4%
380,676
-28.1%
0.02%
-24.0%
Q1 2014$16,688,000529,7570.02%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders